Reacción #368

ord-53ad2bbc851349aeae5fd4d95fae57a4

Ecuación de reacción

CN1Cc2cnc(Cl)nc2O[C@H](c2ccccc2)C1
CN1Cc2cnc(Cl)nc2O[C@
COc1cc(N)ccc1-n1cnc(C)c1
COc1cc(N)ccc1-n1cnc(
COc1cc(Nc2ncc3c(n2)O[C@H](c2ccccc2)CN(C)C3)ccc1-n1cnc(C)c1
COc1cc(Nc2ncc3c(n2)O

Disolventes

Condiciones de reacción

Temperatura
120°CELSIUS

Procedimiento

The aim is optimization. (R)-2-chloro-6-methyl-8-phenyl-5,6,7,8-tetrahydropyrimido[5,4-f][1,4]oxazepine (29 mg, 0.11 mmol), 3-methoxy-4-(4-methyl-1H-imidazol-1-yl)aniline (21.38 mg, 0.11 mmol), Sodium tert-butoxide (15.16 mg, 0.16 mmol), rac-2,2'-Bis(diphenylphosphino)-1,1'-binaphthyl (9.17 mg, 0.01 mmol) and Tris(dibenzylideneacetone)dipalladium(0) (6.74 mg, 7.36 µmol) were added to a microwave vial then toluene (1 mL) was added. The reaction mixture was flushed with nitrogen and the mixture was heated to 120°C for 45 min. Small amount of product was formed. Abandoned.

Fuente

750 AstraZeneca ELN dataset